Adequan Canine

Adequan Canine (polysulfated glycosaminoglycan) is recommended for intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints. Adequan Canine is the only FDA-approved disease-modifying osteoarthritis drug (DMOAD) that is proven to inhibit cartilage loss in dogs’ synovial joints. Adequan Canine helps to reduce joint inflammation (a primary cause of osteoarthritis pain), enhance the production of key cartilage components, and aid in the production of healthy synovial fluid. There is no generic version of Adequan Canine.
Adequan Canine should not be used in dogs who are hypersensitive to PSGAG or who have a known or suspected bleeding disorder. It should be used with caution in dogs with renal or hepatic impairment. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

• How to Order Prescription Medications
• Veterinarian Information

Please note that this item requires a veterinarian's prescription.

Three convenient ways to do that are:

1. Let us contact your veterinarian for prescription authorization.
2. Your veterinarian can contact us by fax/phone.
3. You can mail us the original written prescription.

• Request Additional Information
• Label Information
• How to Dispose of Unused Medicines
• Other products by American Regent